Valion Bio, Inc.

VBIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 22, 2026 FORM 8-K
424B3 Oct 21, 2026 424B3
EFFECT Oct 20, 2026
EFFECT Oct 20, 2026
S-3 Oct 16, 2026 REGISTRATION STATEMENT
DEF 14A Oct 16, 2026 DEFINITIVE PROXY STATEMENT
8-K Oct 15, 2026 CURRENT REPORT
8-K Oct 14, 2026 CURRENT REPORT
8-K Oct 8, 2026 CURRENT REPORT
S-3 Oct 8, 2026 REGISTRATION STATEMENT
8-K Oct 6, 2026 FORM 8-K
DRS Oct 5, 2026
PRE 14A Oct 2, 2026 PRELIMINARY PROXY STATEMENT
8-K Oct 1, 2026 CURRENT REPORT
4 Sep 24, 2026
4 Sep 24, 2026
8-K Sep 23, 2026 FORM 8-K
3 Sep 17, 2026
3 Sep 17, 2026
SCHEDULE 13G/A Sep 4, 2026
SCHEDULE 13D/A Sep 3, 2026
SCHEDULE 13D/A Sep 2, 2026
8-K Sep 1, 2026 FORM 8-K
SCHEDULE 13D/A Aug 27, 2026
8-K Aug 27, 2026 CURRENT REPORT
← Newer Page 1 of 16 · 398 filings Older →